-
EP1799245
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1799245
| EP1799245 - USE OF ANGIOTENSIN-(1-7) FOR PREVENTING AND/OR REDUCING THE FORMATION OF NEOINTIMA [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.08.2010 Database last updated on 20.07.2024 | Most recent event Tooltip | 13.08.2010 | Application deemed to be withdrawn | published on 15.09.2010 [2010/37] | Applicant(s) | For all designated states Stichting Klinische Farmacologie Groningen Antonius Deusinglaan 1 9713 AV Groningen / NL | [2007/26] | Inventor(s) | 01 /
ROKS, Antonius, Jacobus, Marinus Marwixstraat 18 NL-9726 CD Groningen / NL | 02 /
PINTO, Yigal-Martin Burg. van Laarstraat 35 NL-6267 EV Cadier en Keer / NL | 03 /
HENNING, Robert, Henk Molenweg 62 NL-9919 AJ Loppersum / NL | 04 /
VAN GILST, Wiekert, Hendrikus Rijksstraatweg 219 NL-9752 CA Haren / NL | [2007/26] | Representative(s) | van Loon, C.J.J. Vereenigde Johan de Wittlaan 7 2517 JR Den Haag / NL | [N/P] |
| Former [2007/26] | van Loon, C.J.J. VEREENIGDE Johan de Wittlaan 7 2517 JR Den Haag / NL | Application number, filing date | 05787329.1 | 19.09.2005 | [2007/26] | WO2005NL00681 | Priority number, date | US20040946329 | 20.09.2004 Original published format: US 946329 | [2007/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006049490 | Date: | 11.05.2006 | Language: | EN | [2006/19] | Type: | A1 Application with search report | No.: | EP1799245 | Date: | 27.06.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.05.2006 takes the place of the publication of the European patent application. | [2007/26] | Search report(s) | International search report - published on: | EP | 11.05.2006 | Classification | IPC: | A61K38/08, A61F2/06, A61P9/14, A61P17/02 | [2007/26] | CPC: |
A61K38/1866 (EP,US);
A61K38/085 (EP,US);
A61K38/1825 (EP,US);
A61K38/1891 (EP,US);
A61P17/02 (EP);
A61P43/00 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
A61P9/14 (EP);
A61K48/00 (EP,US)
(-)
| C-Set: |
A61K38/085, A61K2300/00 (US,EP);
A61K38/1825, A61K2300/00 (US,EP);
A61K38/1866, A61K2300/00 (EP,US);
A61K38/1891, A61K2300/00 (US,EP) | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/26] | Extension states | AL | 20.04.2007 | BA | 20.04.2007 | HR | 20.04.2007 | MK | 20.04.2007 | YU | 20.04.2007 | Title | German: | VERWENDUNG VON ANGIOTENSIN-(1-7) ZUR PRÄVENTION UND/ODER VERRINGERUNG DER BILDUNG VON NEOINTIMA | [2007/26] | English: | USE OF ANGIOTENSIN-(1-7) FOR PREVENTING AND/OR REDUCING THE FORMATION OF NEOINTIMA | [2007/26] | French: | EMPLOI D ANGIOTENSINE-(1-7) DANS LA PRÉVENTION ET/OU LE RALENTISSEMENT DE LA FORMATION D'UNE NÉOINTIMA | [2007/26] | Entry into regional phase | 20.04.2007 | National basic fee paid | 20.04.2007 | Designation fee(s) paid | 20.04.2007 | Examination fee paid | Examination procedure | 20.04.2007 | Examination requested [2007/26] | 23.07.2007 | Despatch of a communication from the examining division (Time limit: M06) | 30.01.2008 | Reply to a communication from the examining division | 01.04.2010 | Application deemed to be withdrawn, date of legal effect [2010/37] | 03.05.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2010/37] | Fees paid | Renewal fee | 17.09.2007 | Renewal fee patent year 03 | 15.07.2008 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.09.2009 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO03072059 (UNIV WAKE FOREST [US], et al); |